KEGG   PATHWAY: cfa00512
Entry
cfa00512                    Pathway                                
Name
Mucin type O-glycan biosynthesis - Canis lupus familiaris (dog)
Description
O-glycans are a class of glycans that modify serine or threonine residues of proteins. Biosynthesis of O-glycans starts from the transfer of N-acetylgalactosamine (GalNAc) to serine or threonine. The first GalNAc may be extended with sugars including galactose, N-acetylglucosamine, fucose, or sialic acid, but not mannose, glucose, or xylose. Depending on the sugars added, there are four common O-glycan core structures, cores 1 through 4, and an additional four, cores 5 though 8. Mucins are highly O-glycosylated glycoproteins ubiquitous in mucous secretions on cell surfaces and in body fluids. Mucin O-glycans can be branched, and many sugars or groups of sugars are antigenic. Important modifications of mucin O-glycans include O-acetylation of sialic acid and O-sulfation of galactose and N-acetylglucosamine.
Class
Metabolism; Glycan biosynthesis and metabolism
Pathway map
cfa00512  Mucin type O-glycan biosynthesis
cfa00512

Module
cfa_M00056  O-glycan biosynthesis, mucin type core [PATH:cfa00512]
Other DBs
GO: 0006493
Organism
Canis lupus familiaris (dog) [GN:cfa]
Gene
474777  GALNT12; polypeptide N-acetylgalactosaminyltransferase 12 isoform X2 [KO:K00710] [EC:2.4.1.41]
480370  GALNT16; polypeptide N-acetylgalactosaminyltransferase 16 [KO:K00710] [EC:2.4.1.41]
607787  GALNT6; polypeptide N-acetylgalactosaminyltransferase 6 isoform X5 [KO:K00710] [EC:2.4.1.41]
477056  GALNT15; polypeptide N-acetylgalactosaminyltransferase 15 isoform X5 [KO:K00710] [EC:2.4.1.41]
489790  GALNT17; polypeptide N-acetylgalactosaminyltransferase 17 isoform X2 [KO:K00710] [EC:2.4.1.41]
482809  GALNT11; polypeptide N-acetylgalactosaminyltransferase 11 isoform X1 [KO:K00710] [EC:2.4.1.41]
483025  GALNT14; polypeptide N-acetylgalactosaminyltransferase 14 isoform X1 [KO:K00710] [EC:2.4.1.41]
478753  GALNT13; polypeptide N-acetylgalactosaminyltransferase 13 isoform X2 [KO:K00710] [EC:2.4.1.41]
480161  GALNT1; polypeptide N-acetylgalactosaminyltransferase 1 isoform X1 [KO:K00710] [EC:2.4.1.41]
485390  GALNT18; polypeptide N-acetylgalactosaminyltransferase 18 isoform X1 [KO:K00710] [EC:2.4.1.41]
489165  GALNT10; polypeptide N-acetylgalactosaminyltransferase 10 isoform X2 [KO:K00710] [EC:2.4.1.41]
488359  GALNT5; polypeptide N-acetylgalactosaminyltransferase 5 isoform X4 [KO:K00710] [EC:2.4.1.41]
611040  GALNTL5; inactive polypeptide N-acetylgalactosaminyltransferase-like protein 5 isoform X1 [KO:K00710] [EC:2.4.1.41]
486771  GALNT7; N-acetylgalactosaminyltransferase 7 isoform X1 [KO:K00710] [EC:2.4.1.41]
478774  GALNT3; polypeptide N-acetylgalactosaminyltransferase 3 isoform X1 [KO:K00710] [EC:2.4.1.41]
486063  GALNTL6; polypeptide N-acetylgalactosaminyltransferase-like 6 [KO:K00710] [EC:2.4.1.41]
486224  GALNT9; polypeptide N-acetylgalactosaminyltransferase 9 isoform X1 [KO:K00710] [EC:2.4.1.41]
486734  GALNT8; probable polypeptide N-acetylgalactosaminyltransferase 8 isoform X1 [KO:K00710] [EC:2.4.1.41]
100682763  GALNT2; polypeptide N-acetylgalactosaminyltransferase 2 isoform X2 [KO:K00710] [EC:2.4.1.41]
102152620  N-acetylgalactosaminyltransferase 7 [KO:K00710] [EC:2.4.1.41]
482314  C1GALT1; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 [KO:K00731] [EC:2.4.1.122]
100685864  C1GALT1C1; C1GALT1-specific chaperone 1 [KO:K09653]
106559390  C1GALT1C1L; LOW QUALITY PROTEIN: C1GALT1-specific chaperone 1-like protein isoform X2 [KO:K09653]
484158  GCNT1; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase [KO:K00727] [EC:2.4.1.102]
487578  GCNT3; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 [KO:K09662] [EC:2.4.1.-]
488946  GCNT4; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 [KO:K09663] [EC:2.4.1.-]
482050  ST3GAL1; CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 1 isoform X3 [KO:K00780] [EC:2.4.3.2 2.4.3.4]
489714  ST3GAL2; CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2 [KO:K03368] [EC:2.4.3.2 2.4.3.4]
100049002  ST6GALNAC1; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 [KO:K03479] [EC:2.4.3.3]
100049005  ST6GALNAC2; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 precursor [KO:K06616] [EC:2.4.3.3]
490205  ST6GALNAC3; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 isoform X3 [KO:K03373] [EC:2.4.3.7]
609133  ST6GALNAC4; alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase [KO:K03374] [EC:2.4.3.7]
484831  B3GNT3; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 [KO:K07970] [EC:2.4.1.146 2.4.1.149]
485176  B3GNT6; acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase [KO:K00739] [EC:2.4.1.147]
485920  B4GALT5; beta-1,4-galactosyltransferase 5 isoform X1 [KO:K09905] [EC:2.4.1.274 2.4.1.-]
Compound
C02189  [Protein]-L-serine
G00023  Tn antigen
G00024  Thomsen-Friedenreich antigen
G00025   
G00026  Sialyl T antigen
G00027   
G00028   
G00029   
G00030   
G00031   
G00032   
G00033   
G00034   
G00035  Sialyl-Tn antigen
G10611  UDP-N-acetyl-D-galactosamine
G10794   
G13153   
Reference
  Authors
Brockhausen I.
  Title
Pathways of O-glycan biosynthesis in cancer cells.
  Journal
Biochim Biophys Acta 1473:67-95 (1999)
DOI:10.1016/S0304-4165(99)00170-1
Reference
  Authors
Iwai T, Inaba N, Naundorf A, Zhang Y, Gotoh M, Iwasaki H, Kudo T, Togayachi A, Ishizuka Y, Nakanishi H, Narimatsu H.
  Title
Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans.
  Journal
J Biol Chem 277:12802-9 (2002)
DOI:10.1074/jbc.M112457200
Reference
  Authors
Korekane H, Taguchi T, Sakamoto Y, Honke K, Dohmae N, Salminen H, Toivonen S, Helin J, Takio K, Renkonen O, Taniguchi N.
  Title
Purification and cDNA cloning of UDP-GlcNAc:GlcNAcbeta1-3Galbeta1-4Glc(NAc)-R [GlcNAc to Gal]beta1,6N-acetylglucosaminyltransferase from rat small intestine: a major carrier of dIGnT activity in rat small intestine.
  Journal
Glycobiology 13:387-400 (2003)
DOI:10.1093/glycob/cwg044
Reference
  Authors
van Die I, van Tetering A, Schiphorst WE, Sato T, Furukawa K, van den Eijnden DH.
  Title
The acceptor substrate specificity of human beta4-galactosyltransferase V indicates its potential function in O-glycosylation.
  Journal
FEBS Lett 450:52-6 (1999)
DOI:10.1016/S0014-5793(99)00462-7
Reference
  Authors
Marcos NT, Pinho S, Grandela C, Cruz A, Samyn-Petit B, Harduin-Lepers A, Almeida R, Silva F, Morais V, Costa J, Kihlberg J, Clausen H, Reis CA
  Title
Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen.
  Journal
Cancer Res 64:7050-7 (2004)
DOI:10.1158/0008-5472.CAN-04-1921
Reference
  Authors
Lee YC, Kaufmann M, Kitazume-Kawaguchi S, Kono M, Takashima S, Kurosawa N, Liu H, Pircher H, Tsuji S
  Title
Molecular cloning and functional expression of two members of mouse NeuAcalpha2,3Galbeta1,3GalNAc GalNAcalpha2,6-sialyltransferase family, ST6GalNAc  III and IV.
  Journal
J Biol Chem 274:11958-67 (1999)
DOI:10.1074/jbc.274.17.11958
Reference
  Authors
Kudelka MR, Ju T, Heimburg-Molinaro J, Cummings RD
  Title
Simple sugars to complex disease--mucin-type O-glycans in cancer.
  Journal
Adv Cancer Res 126:53-135 (2015)
DOI:10.1016/bs.acr.2014.11.002
Reference
  Authors
Yeh JC, Hiraoka N, Petryniak B, Nakayama J, Ellies LG, Rabuka D, Hindsgaul O, Marth JD, Lowe JB, Fukuda M
  Title
Novel sulfated lymphocyte homing receptors and their control by a Core1 extension beta 1,3-N-acetylglucosaminyltransferase.
  Journal
Cell 105:957-69 (2001)
DOI:10.1016/S0092-8674(01)00394-4
Related
pathway
cfa00533  Glycosaminoglycan biosynthesis - keratan sulfate
KO pathway
ko00512   
LinkDB

DBGET integrated database retrieval system